8:15 AM ET
8-K
Divestiture
Imunon Divestiture to VoxelDox Therapeutics, Inc. for $16.5M
Imunon entered into an asset purchase agreement to sell its ThermoDox assets to VoxelDox Therapeutics, which intends to develop the drug for glioblastoma. Imunon will receive a 4.76% equity stake in VoxelDox, up to $16.5 million in clinical and regulatory milestone payments, and royalties on future net sales. The closing is contingent on VoxelDox raising at least $2.5 million in financing.
- Value
- $16.5M
- Counterparty
- VoxelDox Therapeutics, Inc.